Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

Abstract Background Clinically relevant predictive biomarkers to tailor anti-angiogenic therapies to breast cancer (BRC) patient subpopulations are an unmet need. Methods We analyzed tumor vascular density and VEGFR2 protein expression in various subsets of primary human BRCs (186 females; Mean age:...

Descripción completa

Detalles Bibliográficos

Autores principales:	Aejaz Nasir, Timothy R. Holzer, Mia Chen, Michael Z. Man, Andrew E. Schade
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2017-05-01
Colección:	Cancer Cell International
Materias:	Breast cancer HER2 Angiogenesis VEGFR2 Ramucirumab Antiangiogenic therapy
Acceso en línea:	http://link.springer.com/article/10.1186/s12935-017-0427-5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!